Mechanism of Vibrio vulnificus Cytolysin on Rat Platelet Aggregation

Vibrio vulnificus cytolysin의 흰쥐 혈소판 응집 기전

  • Published : 1999.12.01

Abstract

Vibrio vulnificus cytolysin has been incriminated as one of the important virulence determinants in V. vulnificus infection. In the present study, the effects of Vibrio vulnificus cytolysin on platelets were examined. Vibrio vulnificus cytolysin induced platelet aggregation and increased intracellular calcium concentration ($[Ca^{2+}]_i$) of rat platelets. These effects were abolished in $Ca^{2+}-free$ buffer (2 mM EGTA). Cytolysin also potentiated ADP-and collagen-induced platelet aggregation. Lanthanum (2 mM) inhibited cytolysin-diduced platelet aggregation. However, another $Ca^{2+}$ channel blockers, verapamil ($20{\;}{\mu}M$) or mefenamic acid ($20{\;}{\mu}M$) did not block cytolysin-induced platelet aggregation. Osmotic protectants, sucrose (50 mM) and raffinose (50 nM) suppressed platelet aggregation by 35.9% and 63.4%, respectively. V. vulnificus cytolysin increased membrane conductances of platelet membranes. These results suggest that cytolysin-induced platelet aggregation is mediated via lanthanum sensitive-calcium influx which resulted from the pore formation by V. vulnificus cytolysin.

Keywords

References

  1. J. Clin. Microbiol. v.3 no.4 Halophilic Vibrio species isolated from blood cultures Hollis, D. G.;Weaver, R.E.;Baker, C. N.;Thornberry, C.
  2. Lancet v.2 Vibrio ("Beneckea") vulnificus, the bacterium associated with sepsis, septisemia, and the sea Farmer J. J.3d.
  3. N. Eng. J. Med. v.300 no.1 Disease caused by a marine Bibrio. Clinical characteristics and epidemiology Blakes, P. A.;Merson, M. H.;Weaver, R. E.;Hollis, D. G.;Heublein, P. C.
  4. Appl. Environ. Microbiol. v.44 no.6 Distribution and ecology of Vibrio vulnificus and other lactose-fermenting marine vibrios in coastal waters of the southeastern United States Oliver, J. D.;Warner, R.A.;Cleland D. R.
  5. J. Am. Acad. Dermatol. v.9 no.2 Vibrio vulnificus infection. Case report and update since 1970 Wickboldt, L. G.;Sanders, C. V.
  6. Infect. Immun. v.48 no.1 Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus Gray, L. D.;Kreger, A. S.
  7. Infect. Immun. v.33 no.2 Detection of extracellular toxin(s) produced by Vibrio vulnificus Kreger, A.;Lockwood, D.
  8. Microbiol. Immunol. v.32 no.10 Role of the protease in the permeability enhancement by Vibrio vulnificus Miyoshi, S.;Shinoda, S.
  9. Infect. Immun. v.35 no.3 Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness Smith, G. C.;Merkel, J. R.
  10. J. Infect. Dis. v.144 no.3 Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis Kreger, A.;DeChatelet, L.;Shirley, P.
  11. J. Clin. Microbiol. v.19 no.2 Comparative studies and laboratory diagnosis of Vibrio vulnificus, an invasive Vibrio Sp. Desmond, E. P.;Janda, J. M.;Adams, F. I.;Bottone E. J.
  12. Infect. Immun. v.41 no.2 Siderophore production by Vibrio vulnificus Simpson, L. M.;Oliver, J. D.
  13. Infect. Immun. v.45 no.2 Extracellular phospholipase A₂and lysophospholipase produced by Vibrio vulnificus Testa, J.;Daniel, L. W.;Kreger, A. S.
  14. Infect. Immun. v.59 no.1 The extracellular cytolysin of Vibrio vulnificus : inactivation and relationship to virulence in mice Wright, A. C.;Morris, J. G. Jr.
  15. Biochem. Int. v.20 no.5 The correlation between $Ca^2$ influx and inositol 1,4,5-triphosphate (IP₃) formation in platelets stimulated by various agonists Uemura Y.;Sakon, M.;Kawasaki, T.;Shiba, E.;Kambayashi, J.;Mori, T.
  16. J. Am. Acad. Dermatol. v.24 no.3 Vibrio vulnificus septicemia in Koreac: clinical and epidemiological findings in seventy patients Park, S. D.;Shon, H. .S.;Joh, N. J.
  17. Toxicon v.33 no.8 Effects of Stonustoxin (lethal factor from Synanceja horrida venom) on platelet aggregation Khoo, H. E.;Hon, W. M.;Lee, S.H.;Yuen, R.
  18. J. Exp. Med. v.168 no.2 Staphylococcal-toxin promotes blood coagulation via attack on human platelets Bhakdi, S.;Muhly, M.;Mannhardt, U.;Hugo, F.;Klapettek, K.;Mueller-Eckhardt, C.;Roka, L.
  19. Br. J. Pharmacol. v.115 no.3 Activation of rabbit platelets by $Ca^{2+}$ influx and thromboxane A₂release in an external $Ca^{2+}$-dependent manner by zooxanthellatoxin-A, a novel polyol Rho, M. C.;Nakahata, N.;Nakamura, H.;Murai, A.;Ohizumi, Y.
  20. Kor. J. Biochem. v.24 Purification and characterization of cytolysin produced by Vibrio vulnificus Kim, H. R.;Park, S. D.;Park, J. W.;Jeong, M. H.;Kim, J. S.;Park, B. H.
  21. J. Gen. Microbiol. v.30 Isolation and composition of staphylococcal α-toxin Bernheimer, A. W.;Schwartz, L. L.
  22. Pfl gers Arch. v.391 no.2 Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches Hamil, O. P.;Marty, A.;Neher, E.;Sakmann, B.;Sigworth, F. J.
  23. J. Biol. Chem. v.260 no.6 A new generation of $Ca^{2+}$ indicators with greatly improved fluorescence properties Grynkiewicz, G.;Poenie, M.;Tsien, R. Y.
  24. J. Lab. Clin. Med. v.90 no.4 Mechanisms of platelet shape change, aggregation and release induced by collagen, thrombin, or A23187 Kinlough-Rathbone, R. L.;Packham, M. A.;Reimers, H. J.;Cazenave, J. P.;Mustard, J. F.
  25. Annu. Rev. Physiol. v.52 Calcium signaling in human platelets Rink, T. J.;Sage, S. O.
  26. Pharmacol. v.51 no.3 Calcium-induced platelet aggregation in washed platelets from Guniea pigs Miyamae, T.;Oshima, K.;Morikawa, T.;Hagiwara, M.